Characteristics of patient samples used for xenotransplantation
| Patient sample . | Age at diagnosis (y) . | WBC count (109/L) . | Blasts (%) . | Karyotype . | Cytogenetic aberrations . | Outcome . | Barcoding . | Engraftment . |
|---|---|---|---|---|---|---|---|---|
| ALL-45 | 4 | 7.9 | 25 | 46,XX | None | Alive, CR | Yes | No |
| ALL-58 | 18 | 295 | 79 | 46,XY | BCR-ABL | Dead | Yes | Yes |
| ALL-70 | 6 | 7.6 | 45 | 54,XY,+X,+Y,+8,+9,+14,+18,+21,+21[11]/46,XY[4] | DeIKZF1 | Dead | Yes | Yes |
| ALL-78 | 14 | 61 | 90 | 46,XY,9p-[6]/46,XY,9p+[4]/46,XY[2] | None | Alive, CR | No | Yes |
| ALL-79 | 9 | 25 | 96 | 46,XX | None | Alive, CR | No | No |
| ALL-80 | 16 | 3.7 | 57 | 64∼68,XX,−X,+1,add(1)(p13), −3, −4, −4,+5,+6,add(6)(q13) or del(6)?(q13p23), −7,?add(8)(p11), −13, −15, −16, −17, −19,+?20, −22,+1∼7mar[cp8]/46,xx[3] | None | Alive, CR | No | No |
| Patient sample . | Age at diagnosis (y) . | WBC count (109/L) . | Blasts (%) . | Karyotype . | Cytogenetic aberrations . | Outcome . | Barcoding . | Engraftment . |
|---|---|---|---|---|---|---|---|---|
| ALL-45 | 4 | 7.9 | 25 | 46,XX | None | Alive, CR | Yes | No |
| ALL-58 | 18 | 295 | 79 | 46,XY | BCR-ABL | Dead | Yes | Yes |
| ALL-70 | 6 | 7.6 | 45 | 54,XY,+X,+Y,+8,+9,+14,+18,+21,+21[11]/46,XY[4] | DeIKZF1 | Dead | Yes | Yes |
| ALL-78 | 14 | 61 | 90 | 46,XY,9p-[6]/46,XY,9p+[4]/46,XY[2] | None | Alive, CR | No | Yes |
| ALL-79 | 9 | 25 | 96 | 46,XX | None | Alive, CR | No | No |
| ALL-80 | 16 | 3.7 | 57 | 64∼68,XX,−X,+1,add(1)(p13), −3, −4, −4,+5,+6,add(6)(q13) or del(6)?(q13p23), −7,?add(8)(p11), −13, −15, −16, −17, −19,+?20, −22,+1∼7mar[cp8]/46,xx[3] | None | Alive, CR | No | No |
CR, complete response; WBC, white blood cell.